Add one or two companies to compare with Hangzhou Tigermed Consulting Co., Ltd. (300347.SZ)
The comparison shows each company’s latest Scope 1, 2 and 3 emissions, how they changed, its SBTi targets and its carbon credit retirements, and where it sits in its industry. Only reported figures are shown.
Similar pharmaceuticals and biotechnology companies to add
- + Tabuk Pharmaceuticals Manufacturing Companyabout 17,000 tCO₂e Scope 1 and 2 in 2024. Same size band on the SBTi registry
- + Ono Pharmaceutical Co., Ltd. (4528.T)9,700 tCO₂e Scope 1 and 2 in 2025. Same size band on the SBTi registry
- + Bio-Techne Corporation (TECH)about 19,000 tCO₂e Scope 1 and 2 in 2024. Same size band on the SBTi registry
Scope 1 and 2 emissions
- Hangzhou Tigermed Consulting Co., Ltd. (300347.SZ) reports more Scope 1 and 2 emissions than 12 of the other 70 pharmaceuticals and biotechnology companies with a figure for 2023 or later.
These are absolute footprints, so they measure a company’s size as much as its efficiency. A large company can be efficient and still sit near the top.
tCO₂e, latest reported year for each company
- Hangzhou Tigermed Consulting Co., Ltd. (300347.SZ)13,061 tCO₂e, 2024
- Pharmaceuticals and biotechnology median94,489 tCO₂e
Scope 3 emissions
tCO₂e, latest reported year for each company
Change over time
The SBTi cross-sector pathway for 1.5°C asks for about 4.2% less each year. A change needs two reported years at most three years apart, the latest from 2023 or later.
Average change a year, compound, between the two latest reported years
- Hangzhou Tigermed Consulting Co., Ltd. (300347.SZ)down 5.7% a year2023 to 2024
- SBTi 1.5°C referencedown 4.2% a year
Climate targets
Hangzhou Tigermed Consulting Co., Ltd. (300347.SZ)
- Near-term target
- Validated, aligned with 1.5°C
- Target year
- 2030
- Net-zero target
- None
Carbon credit retirements
Tonnes of CO₂e retired, where the company is the named beneficiary
- Hangzhou Tigermed Consulting Co., Ltd. (300347.SZ)None found
Retirements come from public registries (CarbonPlan and VROD) and cover November 2024 onward, matched to companies by name, so a missing figure does not mean a company never retired credits.
Sources
Hangzhou Tigermed Consulting Co., Ltd. (300347.SZ)
How the comparison works
- Each company’s figures are its latest reported year in the emissions registry, from its own filings. A gap means the company has not reported that figure; it is never filled in or estimated.
- A zero or implausibly large figure (Scope 1 and 2 above 100 million tCO₂e, or Scope 3 above 1 billion) is shown with a “figure under review” tag and never ranked.
- The industry position compares a company’s latest Scope 1 and 2 figure from 2023 or later with every other company in the same SBTi industry that has one. It is shown only when at least 10 companies report.
- Profiles Carbon3 prepared ahead of a claim are shown here but left out of industry statistics.
Need a deeper peer review for your company?
Contact us